Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

485
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
485
Bone Disorders01:29

Bone Disorders

3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

258
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders.

The Journal of clinical investigation·2025
Same author

Cell-free DNA for detection and monitoring of extramedullary AML relapse.

HemaSphere·2025
Same author

Sensitive and reliable detection of KIT p.D816V mutation in decalcified archival bone marrow trephines.

Virchows Archiv : an international journal of pathology·2024
Same author

Cytogenetics and genomics in CML and other myeloproliferative neoplasms.

Best practice & research. Clinical haematology·2024
Same author

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.

Breast care (Basel, Switzerland)·2023
Same author

De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same journal

[Hereditary cancer predisposition syndromes-significance of gynecological cancers].

Pathologie (Heidelberg, Germany)·2026
Same journal

Pathodashboard: an epidemiological atlas for tumour diagnostics.

Pathologie (Heidelberg, Germany)·2026
Same journal

Pathologie (Heidelberg, Germany)·2026
Same journal

Pathologie (Heidelberg, Germany)·2026
Same journal

[Genetic diagnostics].

Pathologie (Heidelberg, Germany)·2026
Same journal

[Guideline development for MRD diagnostics in AML as a blueprint for solid tumors].

Pathologie (Heidelberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.8K

[Drug-induced bone marrow changes].

Hans H Kreipe1

  • 1Institut für Pathologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. kreipe.hans@mh-hannover.de.

Pathologie (Heidelberg, Germany)
|August 4, 2022
PubMed
Summary
This summary is machine-generated.

Drug side effects can alter bone marrow cell production and maturation, mimicking diseases like myelodysplastic syndromes (MDS) or aplastic anemia. Identifying the causative drug often requires a detailed patient drug history due to non-specific changes.

Keywords:
Bone marrowBone marrow aplasiaBone marrow hypoplasiaDrug-related side effects and adverse reactionsMyelodysplastic syndrome

More Related Videos

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K

Related Experiment Videos

Last Updated: Sep 2, 2025

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.8K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K

Area of Science:

  • Hematology
  • Toxicology
  • Oncology

Background:

  • Drug-induced alterations in bone marrow cell production are a significant clinical concern.
  • These effects can manifest as quantitative changes (hypoplasia, hyperplasia) or qualitative disturbances in cell maturation.
  • Drug toxicity can affect single cell lineages or the entire bone marrow, simulating various hematological disorders.

Purpose of the Study:

  • To highlight the importance of considering drug side effects in the cytomorphological and histomorphological analysis of bone marrow.
  • To describe the spectrum of bone marrow changes induced by drugs.
  • To emphasize the diagnostic challenges in identifying drug-induced hematological abnormalities.

Main Methods:

  • Review of cytomorphological and histomorphological findings in bone marrow.
  • Analysis of drug-induced effects on hematopoietic cell lineages.
  • Correlation of bone marrow findings with drug exposure and patient history.

Main Results:

  • Drugs can cause hypoplasia, hyperplasia, and disturbed maturation of blood cells, including left shifts and atypia.
  • Bone marrow changes can mimic myelodysplastic syndromes (MDS) and aplastic anemia.
  • The broad spectrum of causative drugs and non-specific changes necessitate a thorough patient drug history for diagnosis.

Conclusions:

  • Cytomorphological and histomorphological bone marrow analysis must account for potential drug-induced side effects.
  • Drug-induced hematological changes are diverse and can mimic primary bone marrow disorders.
  • Identifying the specific drug culprit relies heavily on integrating clinical information, particularly the patient's medication history.